A previous study showed altered purinergic receptor-Ca2+ signaling in endothelial growth factor (EGF)-induced epithelial–mesenchymal transition (EMT) and later in hypoxia-induced EMT in breast cancer cells [18,19]. The gene discussed is P2RX5; the disease is breast carcinoma.